JP2011513034A - 骨セメント組成物 - Google Patents

骨セメント組成物 Download PDF

Info

Publication number
JP2011513034A
JP2011513034A JP2010550818A JP2010550818A JP2011513034A JP 2011513034 A JP2011513034 A JP 2011513034A JP 2010550818 A JP2010550818 A JP 2010550818A JP 2010550818 A JP2010550818 A JP 2010550818A JP 2011513034 A JP2011513034 A JP 2011513034A
Authority
JP
Japan
Prior art keywords
composition
bone
present
component
chitosan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010550818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011513034A5 (enExample
Inventor
マーコスカイ，ジェイ・アレクサンダー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marfly 2 LP
Original Assignee
Marfly 2 LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marfly 2 LP filed Critical Marfly 2 LP
Publication of JP2011513034A publication Critical patent/JP2011513034A/ja
Publication of JP2011513034A5 publication Critical patent/JP2011513034A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Materials For Medical Uses (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2010550818A 2008-03-10 2009-03-10 骨セメント組成物 Pending JP2011513034A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3514108P 2008-03-10 2008-03-10
PCT/US2009/036673 WO2009114535A2 (en) 2008-03-10 2009-03-10 Bone paste composition

Publications (2)

Publication Number Publication Date
JP2011513034A true JP2011513034A (ja) 2011-04-28
JP2011513034A5 JP2011513034A5 (enExample) 2012-05-10

Family

ID=41053827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010550818A Pending JP2011513034A (ja) 2008-03-10 2009-03-10 骨セメント組成物

Country Status (4)

Country Link
US (3) US8470369B2 (enExample)
EP (1) EP2257163A4 (enExample)
JP (1) JP2011513034A (enExample)
WO (1) WO2009114535A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019097885A1 (ja) * 2017-11-16 2019-05-23 三菱電機株式会社 全熱交換素子および全熱交換器

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110118850A1 (en) * 2008-12-13 2011-05-19 Amit Prakash Govil Bioactive Grafts and Composites
US12377189B2 (en) 2008-12-13 2025-08-05 Bioventus Llc Osteoinductive bone implant including harvested demineralized bone and bone morphogenetic proteins bound thereto obtained from the same donor
WO2011071766A2 (en) 2009-12-13 2011-06-16 Amit Prakash Govil Bioactive grafts and composites
ES2855151T3 (es) * 2008-12-13 2021-09-23 Bioventus Llc Método de fabricación de implantes de hueso osteoinductivos
US8936804B2 (en) 2010-01-15 2015-01-20 Rutgers, The State University Of New Jersey Use of vanadium compounds to accelerate bone healing
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
WO2013006798A1 (en) 2011-07-06 2013-01-10 University Of Medicine And Dentistry Of New Jersey Vandium compounds as therapeutic adjuncts for cartilage regeneration and repair
WO2013082295A1 (en) * 2011-11-29 2013-06-06 University Of Medicine And Dentistry Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
JP2015534850A (ja) * 2012-10-25 2015-12-07 ラトガース，ザ ステート ユニバーシティ オブ ニュー ジャージー 脊椎固定を促進するためのインスリン−疑似局所治療補助剤
AU2014235352B2 (en) 2013-03-15 2017-04-27 Arteriocyte Medical Systems, Inc. Compositions of and methods for cancellous bone matrix
CA2923002C (en) * 2013-09-02 2022-12-13 Muffin Incorporated Products comprising an extracellular matrix tissue material and osteogenic protein
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
CN108144047A (zh) * 2017-12-30 2018-06-12 广州润虹医药科技股份有限公司 一种增加骨密度的含壳聚糖的保健组合物及其用途
CN110644076B (zh) * 2019-09-17 2021-10-26 南通大学 一种表面接枝重组表皮生长因子纳米纤维的制备方法
CN116643054B (zh) * 2023-06-02 2025-04-29 中国医科大学附属盛京医院 一种非综合征型唇腭裂产前无创诊断分子标志物c3蛋白及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147860A1 (en) * 2002-02-07 2003-08-07 Marchosky J. Alexander Compositions and methods for forming and strengthening bone
WO2007038009A2 (en) * 2005-09-26 2007-04-05 Depuy Spine, Inc. Tissue augmentation, stabilization and regeneration technique
JP2007517001A (ja) * 2003-12-30 2007-06-28 ビオネトス・ホールディング・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 組織再生法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2215209B (en) 1988-03-14 1992-08-26 Osmed Inc Method and apparatus for biodegradable, osteogenic, bone graft substitute device
CA2062659A1 (en) * 1991-03-12 1992-09-13 Yasutaka Igari Composition for sustained-release of erythropoietin
US5563124A (en) 1991-04-22 1996-10-08 Intermedics Orthopedics/ Denver, Inc. Osteogenic product and process
US5837258A (en) 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
FR2706768B1 (enExample) 1993-05-13 1995-12-01 Inoteb
TW369414B (en) 1994-09-30 1999-09-11 Yamanouchi Pharma Co Ltd Bone formation transplant
IT1302534B1 (it) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per
EP1203074A4 (en) * 1999-06-29 2003-09-10 J Alexander Marchosky BONE FORMATION AND STRENGTHENING COMPOSITIONS AND METHOD
US20050255545A1 (en) 2002-02-01 2005-11-17 Smith Timothy J Regulation of human hematopoietin receptor-like protein
WO2005046746A2 (en) * 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
US9011930B2 (en) 2006-05-01 2015-04-21 Zycal Bioceuticals Healthcare Company, Inc. Nutritional supplement and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147860A1 (en) * 2002-02-07 2003-08-07 Marchosky J. Alexander Compositions and methods for forming and strengthening bone
JP2007517001A (ja) * 2003-12-30 2007-06-28 ビオネトス・ホールディング・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 組織再生法
WO2007038009A2 (en) * 2005-09-26 2007-04-05 Depuy Spine, Inc. Tissue augmentation, stabilization and regeneration technique

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6013041668; Ｌｉｆｅ　Ｓｃｉｅｎｃｅｓ，　２００７，　Ｖｏｌ．８０，　ｐｐ．８９３-９００ *
JPN6013041670; 緒方健一　他: '特集　成長ホルモンおよび細胞増殖因子療法，　重症患者管理とＧｒａｎｕｌｏｃｙｔｅ　Ｃｏｌｏｎｙ　Ｓｔｉｍｕｌａｔｉｎｇ　Ｆａｃｔｏｒ' ＩＣＵとＣＣＵ（集中治療医学） Ｖｏｌ．１６，　Ｎｏ．２, 1992, ｐｐ．１１５-１２１, 医学図書出版株式会社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019097885A1 (ja) * 2017-11-16 2019-05-23 三菱電機株式会社 全熱交換素子および全熱交換器
JPWO2019097885A1 (ja) * 2017-11-16 2019-11-14 三菱電機株式会社 全熱交換素子および全熱交換器

Also Published As

Publication number Publication date
US20090226534A1 (en) 2009-09-10
US20140072638A1 (en) 2014-03-13
WO2009114535A2 (en) 2009-09-17
US20170333485A1 (en) 2017-11-23
WO2009114535A3 (en) 2010-03-04
EP2257163A4 (en) 2012-01-18
US9610304B2 (en) 2017-04-04
EP2257163A2 (en) 2010-12-08
US8470369B2 (en) 2013-06-25

Similar Documents

Publication Publication Date Title
US8470369B2 (en) Bone paste composition
US8563040B2 (en) Compositions and methods for forming and strengthening bone
AU782394B2 (en) Compositions and methods for forming and strengthening bone
US7019192B2 (en) Composition for filling bone defects
US6911212B2 (en) Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects
US9138509B2 (en) Composition for filling bone defects
Alidadi et al. Comparative study on the healing potential of chitosan, polymethylmethacrylate, and demineralized bone matrix in radial bone defects of rat
AU2007289354A1 (en) Demineralized cancellous strip DBM graft
Gani et al. Effectiveness of Combination of Chitosan Gel and Hydroxyapatite From Crabs Shells (Portunus pelagicus) Waste as Bonegraft on Periodontal Network Regeneration Through IL‐1 and BMP‐2 Analysis
US9017740B1 (en) Radiopaque bone repair mixture and method of use
Ehlen et al. Treatment of bone defects and nonunion via novel delivery mechanisms, growth factors, and stem cells: a review
Dabbarh et al. Chitosan based biocomposites for hard tissue engineering
JP6232048B2 (ja) 骨移植片代用材としての部分的に脱アセチル化されたキチンを含む自硬性の生体活性セメント組成物
US20080118542A1 (en) Growth Factor Composition
Gani et al. Research Article Effectiveness of Combination of Chitosan Gel and Hydroxyapatite from Crabs Shells (Portunus pelagicus) Waste as Bonegraft on Periodontal Network Regeneration through IL-1 and BMP-2 Analysis
Perez et al. Advancements in Vertebral Augmentation: Innovations in Biomaterials and Cement Compositions
Çevik et al. Fracture Healing and Current Adjuvant Approaches to Fracture Healing
da Silva Oliveira Development of an Injectable Modified Calcium Phosphate (Bonelike)-Dextrin Hydrogel Biomaterial for Bone Regenaration
Tölli Reindeer-derived bone protein extract in the healing of bone defects: evaluation of various carrier materials and delivery systems

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120309

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130827

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131125

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131202

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131225

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140124

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140916